Lisinopril Cost in Arizona 2026: Cash Price, Medicaid, Insurance, and Compounding

What Does Lisinopril Actually Cost in Arizona Right Now?

Generic lisinopril costs approximately $8 per month at Arizona retail pharmacies when paying cash in 2026, compared with a manufacturer list price near $50 per month. Discount programs routinely drop that further, to as low as $4 at chains with flat-rate generic lists. The branded originator product is rarely dispensed because generics have been available since 2002 and are therapeutically equivalent.

Lisinopril is an ACE inhibitor first approved by the FDA for hypertension in 1987 and later for heart failure and post-myocardial infarction management. The FDA-approved prescribing information confirms indications including hypertension, heart failure (as adjunctive therapy), and acute MI to improve survival. Because the drug is off-patent and manufactured by dozens of suppliers, retail competition keeps prices low across Arizona.

The ALLHAT trial (N=33,357) published in JAMA 2002 remains the foundational evidence base. ALLHAT showed that lisinopril was as effective as chlorthalidone and amlodipine for preventing fatal coronary heart disease and non-fatal MI, establishing it as a first-line antihypertensive. That evidence base, combined with decades of post-patent generic production, is why lisinopril sits on virtually every formulary in the United States at Tier 1 or Tier 2.

Price Breakdown by Arizona Pharmacy Type

| Pharmacy | Estimated Cash Price (30-day, 10 mg) | Notes | |---|---|---| | Walmart (statewide) | $4 | Part of $4 generic list | | Fry's Food/Kroger | $4 | Free with Fry's Rx membership | | Costco Pharmacy | $3, $6 | No membership required for Rx | | CVS / Walgreens | $10, $18 without discount card | GoodRx brings to ~$7 | | Fry's / Safeway with GoodRx | $4, $8 | Varies by zip code | | Independent Arizona pharmacies | $8, $15 | Often negotiable |

Prices for 20 mg and 40 mg tablets are generally in the same range because the cost driver is dispensing, not active ingredient quantity.

Does Arizona Medicaid (AHCCCS) Cover Lisinopril?

Arizona Health Care Cost Containment System (AHCCCS), the state's Medicaid program, covers lisinopril for eligible members. It appears on the AHCCCS Preferred Drug List for hypertension, heart failure, and chronic kidney disease (CKD) indications, typically at no cost to the member at the point of sale.

AHCCCS managed care plans, including Mercy Care, UnitedHealthcare Community Plan Arizona, and Banner University Family Care, each maintain their own formularies. All current plans include at least one ACE inhibitor, and lisinopril is the most commonly listed. The Centers for Medicare and Medicaid Services requires state Medicaid programs to cover outpatient drugs through the Drug Rebate Program, and lisinopril manufacturers participate in that program, meaning AHCCCS plans have a financial incentive to keep it on-formulary.

For AHCCCS members with CKD, guidelines from the American Diabetes Association reinforce ACE-inhibitor use. The ADA Standards of Care 2024 state that ACE inhibitors or ARBs should be used in patients with diabetes and hypertension who have albuminuria, making coverage access medically significant for this population.

To verify your specific plan's coverage, call the member services number on your AHCCCS card, or ask your telehealth or in-person prescriber to run an eligibility check before you fill the prescription.

Which Arizona Insurance Plans Cover Lisinopril?

Nearly every private insurance plan operating in Arizona covers lisinopril at Tier 1 (preferred generic), resulting in a $0, $10 copay per fill for most members. Arizona marketplace plans sold through Healthcare.gov are required under the ACA to cover at least one drug in each therapeutic class, and ACE inhibitors qualify under that requirement.

Medicare Part D plans operating in Arizona, including those administered by Humana, UnitedHealthcare AARP, and Aetna, list lisinopril at Tier 1 on their 2026 formularies. The Medicare Part D standard benefit sets a low-income subsidy that can bring the member cost to $0 for qualifying beneficiaries.

Employer-sponsored plans in Arizona almost universally place lisinopril on the Tier 1 generic tier. A 90-day mail-order supply typically costs $0, $30 depending on the employer's pharmacy benefit design.

What to Do If Your Plan Lists It at a Higher Tier

If your insurer places lisinopril on Tier 2 or higher (which is uncommon but possible with some narrow-formulary plans), your prescriber can submit a formulary exception request. The medical necessity argument is straightforward given the ALLHAT evidence and JNC guidelines recommending ACE inhibitors as first-line agents. The American Heart Association's 2023 hypertension scientific statement supports ACE inhibitor use as a first-line option for hypertension, providing the clinical backing a prescriber needs to support that exception.

Is Compounded Lisinopril Legal in Arizona?

Yes. Compounded lisinopril prepared by a state-licensed 503A compounding pharmacy is legal in Arizona, provided it is made pursuant to a valid patient-specific prescription from a licensed prescriber. Arizona Board of Pharmacy regulations align with federal USP standards and FDA oversight of 503A facilities.

A 503A pharmacy (named after Section 503A of the Federal Food, Drug, and Cosmetic Act) compounds medications for individual patients based on a prescription. This differs from a 503B outsourcing facility, which can compound in bulk without patient-specific prescriptions. FDA guidance on 503A compounding clarifies that 503A pharmacies are subject to state board oversight rather than full FDA manufacturing requirements, provided they meet USP standards.

Practically speaking, compounded lisinopril in Arizona may be prepared in alternative strengths (for example, a 2.5 mg dose not commercially available in quantity), in liquid form for patients who cannot swallow tablets, or combined with another antihypertensive if a licensed prescriber determines that clinically appropriate. The cost of compounded lisinopril varies widely. Some patient-assistance-integrated programs charge $0 per month, while private-pay compounding typically runs $15, $40 per month depending on the formulation complexity.

One important caveat: lisinopril is commercially available and not on the FDA's drug shortage list. Under 503A rules, compounding a copy of a commercially available drug requires a documented clinical reason (such as a specific strength, route, or excipient sensitivity). Your prescriber must include that rationale in the prescription. Arizona Board of Pharmacy inspectors review compliance during routine audits.

Can You Get a Lisinopril Prescription via Telehealth in Arizona?

Telehealth prescribing of lisinopril is fully legal in Arizona in 2026. Arizona removed its in-person visit requirement for telehealth prescribing via ARS Section 36-3602, allowing licensed prescribers to evaluate patients and issue prescriptions through synchronous audio-video encounters. The Arizona Telemedicine Program at University of Arizona has published guidance confirming that standard-of-care requirements apply equally to telehealth and in-person visits.

For lisinopril specifically, a telehealth prescriber will typically review blood pressure readings (self-reported or from a connected home monitor), a basic metabolic panel (to check potassium and creatinine, since ACE inhibitors can raise both), and relevant history including any prior angioedema. The FDA label for lisinopril includes a black-box warning for angioedema risk, making that history check non-negotiable regardless of visit modality.

Most HealthRX patients in Arizona complete the initial telehealth evaluation in under 20 minutes. Follow-up visits for stable hypertension on lisinopril can be as infrequent as every 12 months if home BP readings are well-controlled and labs remain stable.

What Are the Best Discount Programs for Lisinopril in Arizona?

Several programs reliably lower lisinopril costs for Arizona residents who pay cash or whose insurance does not cover it.

GoodRx and RxSaver. Free discount cards that negotiate rates with pharmacy benefit managers. In most Arizona zip codes, GoodRx shows lisinopril (10 mg, 30 tablets) at $4, $9 depending on the pharmacy. No income requirement exists; anyone can use these cards.

Fry's Rx Membership. Fry's Food Stores, which operates 120-plus locations in Arizona, offers a pharmacy membership program that includes a 90-day supply of select generics including lisinopril for $10. That is approximately $3.33 per month.

Walmart $4 Generic Program. Walmart Pharmacy fills a 30-day supply of lisinopril (most doses) for $4 and a 90-day supply for $10 at all Arizona locations. No membership card is required.

NeedyMeds. A nonprofit database that lists both drug-specific patient assistance programs and clinic-based programs. NeedyMeds lists several Arizona Federally Qualified Health Centers (FQHCs) that dispense lisinopril at sliding-scale fees as low as $0 for income-qualifying patients.

340B Program Clinics. Arizona FQHCs and qualifying hospitals participate in the federal 340B Drug Pricing Program, which allows them to purchase drugs at significantly reduced cost and pass savings to uninsured or underinsured patients. HRSA's 340B program database lists participating Arizona entities. Patients seen at a 340B site may receive lisinopril at no cost or near-zero cost regardless of insurance status.

Extra Help / Low-Income Subsidy (LIS). Medicare beneficiaries in Arizona who qualify for Extra Help pay a maximum of $4.50 per generic prescription in 2026. CMS Extra Help eligibility information explains the income and asset thresholds.

How Does Lisinopril Work and Why Is It Prescribed?

Lisinopril inhibits angiotensin-converting enzyme (ACE), blocking conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor. Without it, arterioles relax, peripheral resistance falls, and blood pressure drops. The drug also reduces aldosterone secretion, which lowers sodium retention and decreases preload in heart failure patients.

The clinical evidence behind lisinopril is substantial. ALLHAT (N=33,357), the largest antihypertensive trial ever conducted at the time of publication in 2002, found no significant difference between lisinopril, chlorthalidone, and amlodipine in reducing combined fatal coronary heart disease or non-fatal MI over a mean 4.9 years of follow-up. ALLHAT investigators reported that lisinopril-treated participants had a 6-year blood pressure of 133/75 mmHg versus 134/75 mmHg in the chlorthalidone group, P<0.001 for the primary composite.

For heart failure with reduced ejection fraction, the ATLAS trial (N=3,164) compared high-dose lisinopril (32.5 to 35 mg/day) against low-dose (2.5 to 5 mg/day). ATLAS showed that high-dose lisinopril reduced the combined risk of death or hospitalization by 12% (P<0.002), supporting guideline recommendations to titrate to target doses.

In CKD with proteinuria, ACE inhibitors slow progression by reducing intraglomerular pressure. The AASK trial (N=1,094) in African American patients with hypertensive kidney disease found that ramipril (a close ACE-inhibitor analog) reduced GFR decline more than amlodipine. AASK results inform the ADA and KDIGO 2024 guideline recommendations that clinicians apply to lisinopril given the class effect.

Common Lisinopril Side Effects That Matter for Arizona Patients

Dry cough occurs in roughly 10 to 15% of patients on ACE inhibitors and is the most common reason for discontinuation. FDA prescribing information lists cough as a reported adverse reaction requiring consideration of discontinuation. Patients who develop cough can often switch to an angiotensin receptor blocker (ARB) such as losartan with equivalent blood pressure benefit and no cough risk.

Hyperkalemia is the metabolic concern most relevant to Arizona patients, particularly those with CKD or diabetes who are also on potassium-sparing diuretics or NSAIDs. A baseline and follow-up comprehensive metabolic panel (CMP) 2 to 4 weeks after initiation or dose change is standard practice.

Angioedema is rare (incidence roughly 0.1 to 0.3% in published series) but potentially life-threatening. It occurs more frequently in Black patients. The American Heart Association notes that this risk differential is one reason some guidelines favor thiazides or calcium channel blockers as first-line agents in Black patients without a compelling indication for ACE inhibition.

First-dose hypotension occurs mainly in patients who are volume-depleted, particularly those on diuretics or with heart failure. Starting at 5 mg daily and checking standing blood pressure at the first follow-up visit reduces this risk.

Monitoring Requirements While on Lisinopril in Arizona

The HealthRX clinical team uses a standardized monitoring schedule for Arizona patients prescribed lisinopril through our telehealth platform:

1. Baseline (before first dose): Serum creatinine, potassium, sodium, blood pressure (bilateral arm measurement at first visit).
2. Week 2, 4: Repeat CMP to detect early hyperkalemia or creatinine rise (>30% above baseline warrants dose adjustment or specialist referral).
3. Month 3: Blood pressure review via connected home monitor data or in-clinic reading. Adjust dose to target <130/80 mmHg per AHA/ACC 2017 guidelines if tolerated.
4. Annually: CMP, blood pressure, assessment for cough, pregnancy status in reproductive-age women (lisinopril is Category D and absolutely contraindicated in pregnancy).

Dose titration for hypertension typically starts at 10 mg once daily, with increases every 2 to 4 weeks to a maximum of 40 mg/day. Heart failure dosing starts at 2.5 to 5 mg once daily and titrates toward 20 to 40 mg daily as tolerated.

Lisinopril vs. Other ACE Inhibitors: Does It Matter Which One You Get in Arizona?

For most patients, the choice among lisinopril, enalapril, ramipril, and benazepril is driven by cost and formulary position rather than meaningfully different clinical outcomes. All are renin-angiotensin system inhibitors with class-level evidence for hypertension, heart failure, and CKD.

Lisinopril is unique in that it is excreted unchanged by the kidneys without requiring hepatic activation. Enalapril, by contrast, is a prodrug requiring conversion to enalaprilat in the liver. This distinction matters for patients with severe liver disease. Ramipril carries strong evidence from the HOPE trial (N=9,297) for cardiovascular risk reduction in high-risk patients without overt heart failure. HOPE trial results showed a 22% relative risk reduction in the combined outcome of MI, stroke, or cardiovascular death versus placebo over 5 years.

In Arizona's generic market, lisinopril is the lowest-cost option at most pharmacies, which is the primary practical reason prescribers default to it when no patient-specific factor favors another ACE inhibitor.

Lisinopril Dosing Guide for Arizona Prescriptions

| Indication | Starting Dose | Target Dose | Maximum FDA-Approved Dose | |---|---|---|---| | Hypertension | 10 mg once daily | 20 to 40 mg once daily | 40 mg/day | | Heart failure (adjunct) | 2.5 to 5 mg once daily | 20 to 40 mg once daily | 40 mg/day | | Acute MI (within 24 hours) | 5 mg, then 5 mg at 24 h | 10 mg once daily | 10 mg/day (this indication) | | Renal dose adjustment (CrCl <30 mL/min) | 2.5 mg once daily | Titrate carefully | Based on response | | Hemodialysis patients | 2.5 mg post-dialysis | Titrate carefully | 40 mg/day |

Older adults (age 65 and above) often achieve target blood pressure with lower doses (10 to 20 mg/day) due to reduced renal clearance.